TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CELU

Celularity Inc

Healthcare · Biotechnology

1.30$ +3.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow CELU
Line item 2018 2019 2020 2021 2022 2023 2024 2025
0.0% -5.2% -442.6% -516.0% -767.0% -169.9% -11.8% -49.9%
27.3% 29.3% 57.2% 41.3% 52.5% 40.9% 14.6% 27.5%
25.6% 17.3% 30.6% 187.5% 88.2% 65.9% 21.3% 39.1%
-294.6% 659.9% 326.6% -36.1%
-7.6% 0.6% 25.2% -51.9% -86.0% 14.3% 40.9% 126.5%
10.9% 0.0% 194.9% 29.1% 29.1% 17.8% 0.3% 0.0%
-177.7% -1,356.5% -89.8% -27.7% -29.1% 0.9%
217.3% 0.0% 22.2%
30.7% -1.8% 0.0% -0.7%
-0.7% 0.0% 476.7% -65.0% -25.6% -0.5%
0.1% 1,365.9% 714.5% 462.0% 666.7% 105.8% 12.4% 70.2%
-177.5% 4.2% 182.1% -81.7% -129.5% -81.9% 1.5% 20.3%
-10.9% -5.2% -637.5% -545.1% -796.2% -187.7% -12.1% -49.9%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?